Who can register as a potential blood stem cell donor?
If you are between the ages of 18 and 55-years-old and in general good health, then you may be able to register as a blood stem cell donor.
If you have previously registered with DKMS or another donor center, there is no need to do so again, as you will already be available for searches worldwide. If you have been diagnosed with any chronic or serious illnesses (whether current or in the past), please check with us before signing up.
The National Marrow Donor Program has established medical guidelines that we follow to protect the safety of the donor. The following medical conditions would prevent a person from registering as a donor or from being cleared to donate.
History of heart surgery or heart disease
Autoimmune disorders such as lupus, rheumatoid arthritis or multiple sclerosis
Sleep apnea, breathing problems or severe asthma (daily inhalers are acceptable)
Diabetes requiring insulin or injectable medication
Hepatitis B or C
Kidney or liver disease
History of stroke, including TIA
Multiple concussions or head injuries
Chronic or severe neck or back problems
Epilepsy or other seizure within one year
History of blood clotting or bleeding disorders
Personal history of cancer (exceptions: Stage 0 or in situ melanoma, breast, bladder, cervical and cured localized skin cancer such as basal cell or squamous cell carcinoma)
How are patients matched with donors?
A cheek cell sample is collected at registration. The sample is tested for the HLA tissue type and added to the national donor pool, so doctors can search and find a matching donor for their patient.
To learn more
How does a bone marrow or blood stem cell donation work?
Peripheral stem cell donation
In about 80 percent of the cases the stem cells are taken from the bloodstream. The donor is administered the growth factor G-CSF for five days. This drug increases the number of stem cells in the peripheral blood, which are then obtained directly from the blood using a special procedure. The donation takes 4-8 hours on one or two consecutive days. No surgery is necessary, you can usually leave the clinic the same day. This procedure has been used at DKMS since 1996. During the administration of the drug, flu-like symptoms may occur. Long-term side effects are not known according to the current state of research.
Bone marrow donation
In this method, bone marrow is taken from the donor under general anaesthesia using a special syringe from the iliac crest. Two small incisions in the area of the rear pelvic bone are usually sufficient. The resulting wounds are so small that they only require a few stitches or often no stitches at all and heal quickly. The removal is performed in the prone position and takes about 60 minutes. With bone marrow donation, the risk is essentially limited to the anesthetic. About 5 percent of the bone marrow is taken from the iliac crest. Usually, the donor's bone marrow regenerates completely within 2 to 4 weeks. Local wound pain can occur, similar to a contusion. Only in rare cases can there be pain that lasts longer. The stay in the hospital lasts three days in total. In most cases, as a precautionary measure, a sick note is taken for a few days.
The type of withdrawal depends on the health condition of the patient. A donor should be prepared to use both methods.
What is blood cancer?
Blood cancer is the generic term for malignant diseases of the bone marrow or blood-forming system, in which normal blood formation is disturbed by the uncontrolled multiplication of malignant blood cells. Because of these cancer cells, the blood can no longer perform its vital tasks, such as fighting infections, transporting oxygen or stopping bleeding.
Curing blood cancer
Blood cancer patients can often only overcome the disease with the help of a stem cell donation from a suitable donor. In the case of leukaemia and malignant lymphomas, the transfer of healthy stem cells is even the only chance of a cure.
A series of malignant diseases in which there is a pathologically increased proliferation of immature and therefore non-functional white blood cells. Malignant lymphomas are divided into Hodgkin's disease (lymphogranulomatosis) and non-Hodgkin's lymphomas (lymphatic leukaemia) according to their different characteristics.
Malignant alteration of lymphatic tissue with swelling of the lymph nodes and pathological enlargement of the spleen. Malignant lymphomas are divided according to their different characteristics into Hodgkin's disease (lymphogranulomatosis) and non-Hodgkin's lymphomas (lymphatic leukemia), which originate from the lymph nodes.